FTC Warns Pharma of Patent Manipulation; AbbVie’s Humira Patent Expires
Last week the Federal Trade Commission issued a warning to pharmaceutical companies about exploiting loopholes in the patent process. In particular, patents on inhalers are suspected to be violating federal law. The pharmaceutical companies, which were not named, bar competitors from the drug market by filing patent applications on various aspects of their products. Then …